Delivery Order SPE2DB20D9329-SPE2DB24FZK86
Award Date
7/15/24
Potential Completion Date
8/5/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, on July 30, 2024. The $4,507.92 contract is for the delivery of YF-VAX 1 dose vials with an ultimate completion date of August 20, 2024. This delivery order is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,670.13 contract is for the delivery of 4567790722 units of YF-VAX 1 dose vials, with a completion date of April 15, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,113.42 contract is for the delivery of 4567805880 YF-VAX 1 dose vials, with a period of performance ending on April 22, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,113.42 contract is for the supply of 4567790720 YF-VAX 1 DOSE VIALS and has an ultimate completion date of April 21, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,134.20 and covers the delivery of 4567378279 units of the YF-VAX 1 DOSE VIALS product. The contract has an ultimate completion date of March 5, 2025 and was awarded on February 11, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $11,134.20 contract is for the delivery of YF-VAX 1 dose vials, with a performance period ending on April 28, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a $1,126.98 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of YF-VAX 1-dose vials and has a completion date of June 26, 2024. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, which allows DLA to issue delivery orders for a wide range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,113.42 contract is for the delivery of 4567870435 YF-VAX 1 dose vials, a specialized pharmaceutical product, with a period of performance through April 29, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,833.29 contract is for the delivery of YF-VAX 1 dose vials, a specialized pharmaceutical product, with a completion date of November 26, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $19,158.66, is for the delivery of YF-VAX 1 dose vials, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The contract has a completion date of June 20, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up...